Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.37
-0.2150-3.27%
Volume:17.93M
Turnover:116.49M
Market Cap:2.56B
PE:-3.76
High:6.77
Open:6.36
Low:6.26
Close:6.58
Loading ...

Is Recursion Pharmaceuticals (RXRX) the Cheap AI Stock to Buy in 2025?

Insider Monkey
·
29 Jan

Recursion Pharmaceuticals call volume above normal and directionally bullish

TIPRANKS
·
28 Jan

Nvidia-Linked Stocks Rout; NBIS Plunged 27%, APLD Down 11%

Tiger Newspress
·
27 Jan

Recursion Pharmaceuticals (RXRX): Industrializing Drug Discovery with AI Amid J.P. Morgan’s ‘Neutral’ Outlook

Insider Monkey
·
25 Jan

Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?

Zacks
·
23 Jan

Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday

Insider Monkey
·
23 Jan

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Insider Monkey
·
23 Jan

Stock Track | Recursion Pharmaceuticals Soars 16.40% on Bullish Options Activity

Stock Track
·
22 Jan

Recursion Pharmaceuticals call volume above normal and directionally bullish

TIPRANKS
·
22 Jan

Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth

Insider Monkey
·
19 Jan

Is Recursion Pharmaceuticals Stock a Buy?

Motley Fool
·
17 Jan

Recursion Pharmaceuticals (RXRX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Zacks
·
16 Jan

Stock Track | Recursion Pharmaceuticals Soars 7.75% After Rallying on Fed Rate-Cut Hopes

Stock Track
·
15 Jan

Nvidia-Linked Stocks Surge As Easing Inflation Boosts Fed Rate-Cut Bets

Tiger Newspress
·
15 Jan

24H|Quantum Computing Stocks Surge; QMCO up 17%; D-Wave Quantum Rises 10%; Robotics Stocks, Drone Makers Jump

Tiger Newspress
·
15 Jan

3 Reasons Nvidia Stock Is a Forever Buy and Hold

Motley Fool
·
14 Jan